Clinical Trial Update: Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN) [Phase 3]

View source ↗

Summary

Phase 3 trial update on Suzetrigine (SUZ) assessing long-term safety and effectiveness in painful diabetic peripheral neuropathy. The study status is ACTIVE_NOT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Suzetrigine (SUZ) (Suzetrigine)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 3 | Status: ACTIVE_NOT_RECRUITING